tirzepatide plus semaglutide - Health Care Products - Freedom Primary Care | Weight and Primary Health Centre Semaglutide and Tirzepatide Weight Loss

Here are 8 potential reasons why not to prescribe Lixisenatide: 1- this is only one small study and only one dose was tested, 2- Lixisenatide is not currently available at pharmacies, 3- the weight loss associated with this GLP-1 is not desirable in many cases of Parkinsons disease where weight loss is an issue, 4- non-motor outcomes did not change as in other trials, and this will need to be better explained

Half-life is short, so when you inject affects what you get out of it

Some people feel nothing at all during the first few days, which does not mean the medication is not working

Reduces Hunger and Appetite One of the main reasons tirzepatide helps with weight loss is because it lowers appetite

Emerging research is also investigating the broader systemic effects of GLP-1, GIP, and glucagon receptor agonists, including potential roles in: Metabolic dysfunction research Cardiometabolic health Inflammatory-response pathways Cellular stress and oxidative-stress pathways Neuroprotective and systemic health research Responses and tolerability may vary significantly between individuals depending on dosage, consistency, nutrition, lifestyle, stress, sleep, hormonal balance, and overall metabolic health